Experiment 399266

Worktypes

PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED

Compounds isolated

NARINGIN

Alerts

BIOLOGICAL ACTIVITY REPORTED HAS BEEN PATENTED.DATA INCOMPLETE - DERIVED FROM AN ABSTRACT.

Details

PropertyValue
Pharmacology
HMG-CO-A REDUCTASE INHIBITION
Administration routeINTRAGASTRIC
OrganismEmpty organism
CitationBOK,SH: SON,KH: JEONG,TS: KWON,BM: KIM,YK: CHOI,D: KIM,SU: BAE,KH: PARK YB: CHOI,MS: HWANG,IY: MOON SS: KWON,YK: AHN,JA: LEE,ES:. (1998). NARINGIN AND NARINGENINN AS A 3-HYDROXY-3-METHYLGLUTARYL COA (HMG-COA) REDUCTASE INHIBITOR.. ()
Amount utilized
Compound isolated
Dose amount20.0 MG
Number1
Qualitative resultACTIVE
AnimalRAT
Dose expressionDOSE